lentivirus vector for shRNA for RNAi: pADV-U6-promoter/mCherry/Luciferase reporter (GeneMedi Owned)

GeneMedi's lentivirus U6 expression vector is inserted with a promoter for human U6 to drive gene knockdown. You can contact Genemedi for your unique reporter including GFP, zsgreen, RFP, mcherry or luciferase.U6 is a type III RNA polymerase III promoter commonly used for driving small hairpin RNA (shRNA) expression in vector-based RNAi. You can easily produce a recombinant lentivirus particle in HEK293T or HEK293FT cell line in high titer using GeneMedi's lentivirus Vector System, including the lentivirus expression plasmids (overexpression, shRNA or Crispr-cas9-gRNA), the envelope protein VSV-G expressing plasmid pMD2G and the packaging plasmid pSPAX2.

Target products collectionGo to Lentivirus vector system >>

pdf Lentivirus Protocol pdf Lentivirus User Manual

Product Description

Product Name Organization Type Price(In USD) Qty (Quantity) Sum(In USD)
pGMLV-U6-MCS-EF1-fLuc-T2A-mCherry (Amp resistance)
Cat No.: P-ALV-B38
Expression: shRNA for RNAi
Promoter: U6
Reporter: mCherry/Luciferase
Selection: Null
TAG (unfusion):
Size:5μg		 Academic 2506
pGMLV-U6-MCS-EF1-fLuc-T2A-mCherry (Amp resistance)
Cat No.: P-ALV-B38
Expression: shRNA for RNAi
Promoter: U6
Reporter: mCherry/Luciferase
Selection: Null
TAG (unfusion):
Size:5μg		 Industry R&D
(excluding
CRO&CDMO&CXO)		 Inquiry
pGMLV-U6-MCS-EF1-fLuc-T2A-mCherry (Amp resistance)
Cat No.: P-ALV-B38
Expression: shRNA for RNAi
Promoter: U6
Reporter: mCherry/Luciferase
Selection: Null
TAG (unfusion):
Size:5μg		 CRO&CDMO&
CXO&CMC&
Manufacturing company		 Inquiry
pGMLV-U6-MCS-EF1-fLuc-T2A-mCherry (Amp resistance)
Cat No.: P-ALV-B38
Expression: shRNA for RNAi
Promoter: U6
Reporter: mCherry/Luciferase
Selection: Null
TAG (unfusion):
Size: ≥10mg		 All Inquiry
pGMLV-U6-MCS-EF1-fLuc-T2A-mCherry (Kan resistance)
Cat No.: P-ALV-B38-Kan
Expression: shRNA for RNAi
Promoter: U6
Reporter: mCherry/Luciferase
Selection: Null
TAG (unfusion):
Size: ≥10mg		 All Inquiry
Shipping Cost: 169.00
Total:
GeneMedi offers both seed and amplification services for the Amp-resistant Lentivirus expression plasmids.
GeneMedi only offers amplification services and do not provide seed for the Kan-resistant Lentivirus expression plasmids currently.
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service
Terms of sale:
For Seed (5ug):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party.
For plasmid production & amplification (≥10mg):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party.

Citation

Title Publication Date
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides Nature 2023/12/13
Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1 Molecular Cancer 2023/7/17
LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer Molecular Cancer 2022/7/16
T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy Nature Nanotechnology 2021/9/27
HTML] Chronic pulmonary bacterial infection facilitates breast cancer lung metastasis by recruiting tumor-promoting MHCIIhi neutrophils Signal Transduction and Targeted Therapy 2023/8/11
Pancreatic acinar cells-derived sphingosine-1-phosphate contributes to fibrosis of chronic pancreatitis via inducing autophagy and activation of pancreatic stellate cells Gastroenterology 2023/8/25
Satellite‐based On‐orbit Printing of 3d Tumor Models Advanced Materials 2023/12/25
Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10 Molecular Cancer 2022/3/10
Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation Molecular Cancer 2022/4/2
Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis Molecular Cancer 2022/3/10